Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T18:46:23.011Z.
Calculation as of: 2026-10-06T18:46:23.011Z.
Quote observation: 2026-10-06T18:45:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a99f3f088f54f9f9c0225e5104dac3e52b54f392bb47ad8d1f9af79329b73e7d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$4.39B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.44B
EV/EBIT Ratio
9.12x
TTM Avg
11.90x
3Y Avg
40.42x
5Y Avg
37.42x
Market Cap
$4.07B
EV/EBIT Ratio
N/A
TTM Avg
9.12x
3Y Avg
14.02x
5Y Avg
14.02x
Market Cap
$3.96B
EV/EBIT Ratio
45.36x
TTM Avg
60.24x
3Y Avg
289.81x
5Y Avg
268.55x
Market Cap
$4.65B
EV/EBIT Ratio
16.92x
TTM Avg
15.96x
3Y Avg
18.18x
5Y Avg
22.57x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | $4.30B | N/A | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.39B | N/A | N/A | N/A | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.43B | N/A | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.44B | 9.12x | 11.90x | 40.42x | 37.42x |
| LivaNova PLC (LIVN)vs › | $4.13B | 19.98x | 18.41x | 129.51x | 140.01x |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.03B | N/A | N/A | N/A | N/A |
| AbCellera Biologics Inc. (ABCL)vs › | $4.07B | N/A | 9.12x | 14.02x | 14.02x |
| ICU Medical, Inc. (ICUI)vs › | $3.96B | 45.36x | 60.24x | 289.81x | 268.55x |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 16.92x | 15.96x | 18.18x | 22.57x |
| BillionToOne, Inc. (BLLN)vs › | $4.68B | 98.71x | 157.20x | 157.20x | 157.20x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
